Remove Article Remove Chronic Condition Remove Finance Remove Utilities
article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law

Today we offer the article below on one of those pieces: an HHS report released to the public last Thursday outlining the Biden Administration’s strategies on drug pricing and payment reform. Medicare negotiation authority; encourage biosimilars and generic drug utilization). Part D currently has no such cap.